Phase 3 Bilateral Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Bilateral Nasal Polyposis
Optinose US Inc.72 enrolled40 locationsNCT03747458
Recruiting
Phase 3
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
ObesePCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
University of Colorado, Denver80 enrolled1 locationNCT05819853
Active
Phase 2Phase 3
Clinical Investigation of the Extended Range of Vision (ERV) Intraocular Lenses (IOLs), Model XRA03 and Toric Series ZXT in Participants Requiring Bilateral Cataract Removal and Lens Replacement.
Bilateral Cataract removal and replacment of crystalline lens with an investigational extended range of vision IOL, in otherwise healthy eyes
Abbott Medical Optics Inc75 enrolled1 locationACTRN12613001189718
Completed
Phase 3
CeMyLungs
Heart Lung, Bilateral Lung and Single Lung Transplant recipients
Professor Allan R. Glanville320 enrolled1 locationACTRN12605000141640